Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats
- PMID: 1365863
- DOI: 10.1007/BF02247724
Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats
Abstract
This study was designed to assess whether rats made tolerant to the suppressant action on Fixed Ratio operant responding of the benzodiazepine (BZ) chlordiazepoxide (CDP) would show behavioural disruption on drug withdrawal--so-called operant behavioural dependence. In addition, the study examined the effects of the 5-HT3 antagonist ondansetron on such operant behavioural dependence. During 42 consecutive days of CDP treatment, at doses escalated from 10 to 30 mg/kg/day, marked tolerance developed to the rate-suppressant action of CDP. On subsequent days, during spontaneous withdrawal, response rates declined significantly by around 30% in animals treated with saline, although some recovery of responding was seen over successive days of withdrawal. Similar reductions in responding followed by recovery were seen in rats treated with the 5-HT3 antagonist ondansetron (0.01-0.1 mg/kg, b.i.d.). These findings demonstrate for the first time that it is possible to use operant procedures to detect spontaneous BZ withdrawal. They also suggest, in agreement with recent studies from this laboratory (Leathley and Goudie 1992), that 5-HT3 antagonists may have relatively limited utility in treating some signs of BZ dependence.
Similar articles
-
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.Drugs. 1996 Nov;52(5):773-94. doi: 10.2165/00003495-199652050-00010. Drugs. 1996. PMID: 9118822 Review.
-
Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.Psychopharmacology (Berl). 1995 Mar;118(1):57-64. doi: 10.1007/BF02245250. Psychopharmacology (Berl). 1995. PMID: 7597123
-
Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.Psychopharmacology (Berl). 1991;105(3):322-8. doi: 10.1007/BF02244425. Psychopharmacology (Berl). 1991. PMID: 1839177
-
Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.Eur J Pharmacol. 1990 Aug 28;185(2-3):179-86. doi: 10.1016/0014-2999(90)90638-m. Eur J Pharmacol. 1990. PMID: 1979273
-
Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward.Psychopharmacology (Berl). 1997 Nov;134(1):64-72. doi: 10.1007/s002130050426. Psychopharmacology (Berl). 1997. PMID: 9399368
Cited by
-
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.Drugs. 1996 Nov;52(5):773-94. doi: 10.2165/00003495-199652050-00010. Drugs. 1996. PMID: 9118822 Review.
-
Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.Psychopharmacology (Berl). 1994 Jun;115(1-2):86-94. doi: 10.1007/BF02244756. Psychopharmacology (Berl). 1994. PMID: 7862917
-
The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.Drugs. 1997 Jan;53(1):20-39. doi: 10.2165/00003495-199753010-00003. Drugs. 1997. PMID: 9010647 Review.
-
Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.Psychopharmacology (Berl). 1995 Mar;118(1):57-64. doi: 10.1007/BF02245250. Psychopharmacology (Berl). 1995. PMID: 7597123
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical